LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 6.21 | 21.74 | 744 | 392 | 1.8980 | 1.3320 | MN20160310_N01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 6.21 | 21.74 | 1 | 392 | 0.0026 | -0.5219 | MN20160310_N01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 6.21 | 21.74 | 720 | 392 | 1.8367 | 1.3137 | MN20160310_N01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 8.19 | 21.74 | 56 | 439 | 0.1273 | 0.2437 | MN20160310_N01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 8.19 | 21.74 | 728 | 439 | 1.6551 | 1.2463 | MN20160310_N01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 8.19 | 21.74 | 1 | 439 | 0.0023 | -0.5082 | MN20160310_N01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 8.19 | 21.74 | 781 | 439 | 1.7756 | 1.2830 | MN20160310_N01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 10.16 | 21.74 | 76 | 463 | 0.1639 | 0.3278 | MN20160310_N01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 10.16 | 21.74 | 835 | 463 | 1.8010 | 1.2851 | MN20160310_N01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 10.16 | 21.74 | 1 | 463 | 0.0022 | -0.5022 | MN20160310_N01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 10.16 | 21.74 | 779 | 463 | 1.6802 | 1.2495 | MN20160310_N01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 12.13 | 21.74 | 93 | 496 | 0.1874 | 0.3800 | MN20160310_N01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 12.13 | 21.74 | 858 | 496 | 1.7286 | 1.2579 | MN20160310_N01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 12.13 | 21.74 | 5 | 496 | 0.0101 | -0.2780 | MN20160310_N01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 12.13 | 21.74 | 789 | 496 | 1.5896 | 1.2163 | MN20160310_N01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 14.10 | 21.74 | 106 | 540 | 0.1960 | 0.4073 | MN20160310_N01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 14.10 | 21.74 | 865 | 540 | 1.5991 | 1.2131 | MN20160310_N01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 14.10 | 21.74 | 1 | 540 | 0.0018 | -0.4852 | MN20160310_N01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 14.10 | 21.74 | 828 | 540 | 1.5307 | 1.1923 | MN20160310_N01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 16.07 | 21.74 | 124 | 597 | 0.2074 | 0.4393 | MN20160310_N01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 16.07 | 21.74 | 882 | 597 | 1.4753 | 1.1694 | MN20160310_N01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 16.07 | 21.74 | 1 | 597 | 0.0017 | -0.4748 | MN20160310_N01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 16.07 | 21.74 | 843 | 597 | 1.4100 | 1.1490 | MN20160310_N01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 18.04 | 21.74 | 170 | 750 | 0.2265 | 0.4956 | MN20160310_N01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 18.04 | 21.74 | 902 | 750 | 1.2018 | 1.0732 | MN20160310_N01 | C21 |